Compound details
6-amino-5-cyano-2-[[(3-cyano-4,6-dimethyl-2-pyridinyl)thio]methyl]-4-phenyl-4H-pyran-3-carboxylic acid ethyl ester
| Compound ID | CDAMM00197 |
|---|---|
| Common name | 6-amino-5-cyano-2-[[(3-cyano-4,6-dimethyl-2-pyridinyl)thio]methyl]-4-phenyl-4H-pyran-3-carboxylic acid ethyl ester | IUPAC name | ethyl 6-amino-5-cyano-2-[(3-cyano-4,6-dimethylpyridin-2-yl)sulfanylmethyl]-4-phenyl-4H-pyran-3-carboxylate |
| Molecular formula | C24H22N4O3S |
| Retention time | 21.01 |
|---|---|
| Adduct | [M+K]+ |
| Actual mz | 485.104 | Theoretical mz | 485.104 |
| Error | 1.25 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 4.7983 |
| Inchi key | RTKWILSYKYJSQX-UHFFFAOYNA-N |
|---|---|
| Smiles | CCOC(=O)C1=C(OC(=C(C1C2=CC=CC=C2)C#N)N)CSC3=C(C(=CC(=N3)C)C)C#N |
| Superclass | Organosulfur compounds |
| Class | Thioethers |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P53779 | MAPK10 | c-Jun N-terminal kinase 3 | T85421 | SEA |
| P43003 | SLC1A3 | Excitatory amino acid transporter 1 | T86582 | SEA |
| Q9UIQ6 | LNPEP | Cystinyl aminopeptidase | T97537 | SEA |
| Q13936 | CACNA1C | Voltage-gated L-type calcium channel alpha-1C subunit | T51115 | SEA |
| Q01668 | CACNA1D | Voltage-gated L-type calcium channel alpha-1D subunit | T24793 | SEA |
| P49862 | KLK7 | Kallikrein-7 | T79155 | SEA |
| Q9UBS0 | RPS6KB2 | Ribosomal protein S6 kinase beta-2 | T42760 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T85421 | DI0125 | Dissociative neurological symptom disorder | [ICD-11: 6B60] | P53779 | MAPK10 |
| T51115 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | Q13936 | CACNA1C |
| T24793 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | Q01668 | CACNA1D |
| T42760 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q9UBS0 | RPS6KB2 |